Search by Drug Name or NDC

NDC 00713-0166-12 MIGERGOT 100; 2 mg/1; mg/1 Details

MIGERGOT 100; 2 mg/1; mg/1

MIGERGOT is a RECTAL SUPPOSITORY in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is CAFFEINE; ERGOTAMINE TARTRATE.

MedlinePlus Drug Summary

The combination of ergotamine and caffeine is used to prevent and treat migraine headaches. Ergotamine is in a class of medications called ergot alkaloids. It works together with caffeine by preventing blood vessels in the head from expanding and causing headaches.

Related Packages: 00713-0166-12
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Ergotamine and Caffeine

Product Information

NDC	00713-0166
Product ID	0713-0166_ee9c58f6-c353-2cf3-e053-2a95a90a3f5e
Associated GPIs	67991002105220
GCN Sequence Number	004499
GCN Sequence Number Description	ergotamine tartrate/caffeine SUPP.RECT 2-100MG RECTAL
HIC3	H3F
HIC3 Description	ANTIMIGRAINE PREPARATIONS
GCN	72930
HICL Sequence Number	001868
HICL Sequence Number Description	ERGOTAMINE TARTRATE/CAFFEINE
Brand/Generic	Generic
Proprietary Name	MIGERGOT
Proprietary Name Suffix	n/a
Non-Proprietary Name	Ergotamine Tartrate and Caffeine
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	SUPPOSITORY
Route	RECTAL
Active Ingredient Strength	100; 2
Active Ingredient Units	mg/1; mg/1
Substance Name	CAFFEINE; ERGOTAMINE TARTRATE
Labeler Name	Cosette Pharmaceuticals, Inc.
Pharmaceutical Class	Central Nervous System Stimulant [EPC], Central Nervous System Stimulation [PE], Ergotamine Derivative [EPC], Ergotamines [CS], Methylxanthine [EPC], Xanthines [CS]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA086557
Listing Certified Through	2024-12-31

Package

NDC 00713-0166-12 (00713016612)

Pricing Information	N/A
NDC Package Code	0713-0166-12
Billing NDC	00713016612
Package	12 SUPPOSITORY in 1 BOX (0713-0166-12)
Marketing Start Date	1983-10-30
NDC Exclude Flag	N